Efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell-lung cancer: a systematic review and meta-analysis.

Huai-Qing Xiao,Rong-Hua Tian,Zhi Hao Zhang,Kai-Qi Du,Yi-Ming Ni

Efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell-lung cancer: a systematic review and meta-analysis.

2016

Huai-Qing Xiao
Rong-Hua Tian
Zhi Hao Zhang
Kai-Qi Du
Yi-Ming Ni

Purpose To assess the efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell lung cancer (NSCLC) through a trial-level meta-analysis.

Keywords:

Pemetrexed
Lung cancer
Oncology
Chemotherapy
Internal medicine
Medicine
Randomized controlled trial
non small cell
pooled analysis
first line treatment
Meta-analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations